Back to FMR LLC FMR LLC

SYRESYRE
7 quarters

Position history for FMR LLCFMR LLC's holdings in Spyre Therapeutics, Inc

FMR LLC holds 13M shares of SYRE (Spyre Therapeutics, Inc), worth $1.2B as of 2026-Q2. The position was increased (+10.6% shares). SYRE represents 0.1% of FMR LLC's portfolio.

Current Value

$1.2B

Current Shares

13M

Total Value Change

+$951.6M

Total Shares Change

+4.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
13M
+10.6%
$1.2B0.1%$88.78
35
2026-Q1
Increased
11.8M
+1.2%
$594.2M0.0%$40.07
32
2025-Q4
Increased
11.6M
+28.5%
$381.3M0.0%$31.88
39
2025-Q3
Increased
9.1M
+0.1%
$151.8M0.0%$16.36
30
2025-Q2
Increased
9.1M
+0.2%
$135.5M0.0%$15.22
30
2025-Q1
Increased
9M
+2.7%
$145.8M0.0%$17.94
31
2024-Q4
New
8.8M
-
$204.9M0.0%$22.54
42

Other major holders of SYRE: BlackRock, Inc., RTW INVESTMENTS, LP, VANGUARD CAPITAL MANAGEMENT LLC, STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used